UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042519
Receipt number R000048537
Scientific Title Remimazolam and Body Weight
Date of disclosure of the study information 2020/11/24
Last modified on 2020/11/22 23:24:07

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Remimazolam and Body Weight

Acronym

R-BW

Scientific Title

Remimazolam and Body Weight

Scientific Title:Acronym

R-BW

Region

Japan


Condition

Condition

general anesthesia

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

What is the best body weight to determine infusion rate of remimazolam?

Basic objectives2

PK,PD

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

intraoperative anesthesia depth measured with SedLine

Key secondary outcomes

intraoperative cardiac parameters


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Dose comparison

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Intraoperative remimazolam infusion rate is determined by real body weight.

Interventions/Control_2

Intraoperative remimazolam infusion rate is determined by ideal body weight based on height.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

15 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

scheduled patients who receive orthopedic disease

Key exclusion criteria

patients getting hemodialysis

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Hiroshi
Middle name
Last name Sakamoto

Organization

Shin Sapporo Orthopaedic Hospital

Division name

Anesthesia

Zip code

0630812

Address

Atsubetsuminami2cyome #2-32, Atsubetsu-ku, Sapporo

TEL

011-893-1161

Email

sakamoto@s-s-orth-hp.or.jp


Public contact

Name of contact person

1st name Hiroshi
Middle name
Last name SAKAMOTO

Organization

Shin Sapporo Orthopaedic Hospital

Division name

Anesthesia

Zip code

004-0022

Address

Atsubetsu2cyome #2-32, Atsubetsu-ku, Sapporo

TEL

011-893-1161

Homepage URL

http://www.s-s-orth-hp.or.jp/index.html

Email

sakamoto@s-s-orth-hp.or.jp


Sponsor or person

Institute

Division of Anesthesia, Shin Sapporo Orthopaedic Hospital

Institute

Department

Personal name



Funding Source

Organization

Division of Anesthesia, Shin Sapporo Orthopaedic Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shin Sapporo Orthopaedic Hospital

Address

Atsubetsu2cyome #2-32, Atsubetsu-ku, Sapporo

Tel

0118931161

Email

sakamoto@s-s-orth-hp.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

医療法人新札幌整形外科病院


Other administrative information

Date of disclosure of the study information

2020 Year 11 Month 24 Day


Related information

URL releasing protocol

http://www.s-s-orth-hp.or.jp/index.html

Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2020 Year 08 Month 07 Day

Date of IRB

2020 Year 08 Month 07 Day

Anticipated trial start date

2020 Year 11 Month 25 Day

Last follow-up date

2021 Year 06 Month 03 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 11 Month 22 Day

Last modified on

2020 Year 11 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048537


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name